Silent latency periods in methylmercury poisoning and in neurodegenerative disease

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 5, 2002, Pages 851-854

  Weiss, Bernard ^a   Clarkson, Thomas W ^a   Simon, William ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Hormesis; Latency; Methylmercury; Neurodegenerative disease; Neurotoxicology

Indexed keywords

METHYLMERCURY;

ARTICLE; BRAIN INJURY; BREAD; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; FOOD INTAKE; HUMAN; JAPAN; LONG TERM EXPOSURE; MERCURIALISM; PARKINSON DISEASE; POLIOMYELITIS; PRIMATE; PRIORITY JOURNAL; SYMPTOMATOLOGY;

PRIMATES;

EID: 0036803999     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s5851     Document Type: Article

References (24)

1. Nierenberg DW, Nordgen RE, Chang MB, Siegler R, Blayney MG, Hochberg F, Toribara TY, Cernichiari E, Clarkson T. Delayed cerebellar disease and death after accidental exposure to dimethylmercury. N Engl J Med 338(23):1672-1676 (1998).
2. Ostlund K. Studies on the metabolism of methyl mercury and di-methyl mercury in mice. Acta Pharmacol Toxicol 27(suppl):1-136 (1969).
3. Cernichiari E, Toribara TY, Liang L, Marsh DO, Berlin M, Myers GJ, Cox C, Choisy O, Davidson PW, Clarkson TW. The biological monitoring of mercury in the Seychelles study. Neurotoxicology 16:613-628 (1995).
4. WHO: Environmental Health Criteria 101: Methylmercury. Geneva:World Health Organization, 1990.
5. Hunter D. The Disease of Occupations. Boston:Little Brown, 1969;317-318.
6. Tsubaki T, Irukayama K, eds. Mimamata Disease. Methylmercury Poisoning in Minamata and Niigata, Japan. Tokyo: Kodansha Ltd, 1977;166.
7. Bakir F, Damluji SF, Amin-Zaki L, Murtadha M, Khalidi A, Al-Rawi NY, Tikriti S, Dhahir HI, Clarkson TW, Smith JC, et al. Methylmercury poisoning in Iraq. Science 181:320-241 (1973).
8. Clarkson TW. Environmental contaminants in the food chain. Am J Clin Nutr 61(suppl)628S-686S (1995).
9. Vahter M, Motter NK, Friberg L, Birger L, Shen DD, Burbacher T. Speciation of mercury in the primate blood and brain following long-term exposure to methyl mercury. Toxicol Appl Pharmacol 124:221-229 (1994).
10. Magos L, Brown AW, Sparrow S, Bailey E. Snowden RT, Skipp WR. The comparative toxicology of ethyl- and methylmercury. Arch Toxicol 57:260-267 (1985).
11. Berlin M, Nordberg G, Hellberg J. The uptake and distribution of methyl mercury in the brain of Saimiri sciureus in relation of behavioral and morphological changes. In: Mercury, Mercurials and Mercaptans (Miller MW, Clarkson TW, eds). Springfield, II:Charles C. Thomas, 1973;187-208.
12. Woods J. Personal communication.
13. Thompson SA, White CC, Krejsa CM, Diaz D, Woods JS, Eaton DL, Kavanagh TJ. Induction of glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) in the brains of adult female mice subchronically exposed to methylmercury. Toxicol Lett 110:1-9 (1999).
14. Miura K, Clarkson TW, Ikeda K, Naganuma A, Imura N. Establishment and characterization of methylmercury-resistant PC12 cell line. Environ Health Perspect 102(suppl 3):313-315 (1994).
15. Rice D. Evidence of delayed neurotoxicity produced by methylmercury. Neurotoxicology 17:583-596 (1996).
16. Igata A. Epidemiological and clinical features of Minamata Disease. In: Advances in Mercury Toxicology (Suzuki T, Imura N, Clarkson TW, eds). New York:Plenum Press, 1991;439-457.
17. Evans HL, Garmen RH, Weiss B. Methylmercury: exposure duration and regional distribution as determinants of neurotoxicity in nonhuman primates. Toxicol Appl Pharmacol 41:15-33 (1977).
18. Weiss B, Simon W. Quantitative perspectives on the long term toxicity of methylmercury and similar poisons. In: Behavioral Toxicology (Weiss B, Laties VG, eds). New York:Plenum Press, 1975;429-438.
19. Calne DB, Eisen A, McGeer E, Spencer P. Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment? Lancet 2(8515):1067-1070 (1986).
20. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13:290-296 (1990).
21. Martyn CN, Barker DJ, Osmond C. Motoneuron disease and past poliomyelitis in England and Wales. Lancet 1(8598):1319-1322 (1988).
22. Cory-Slechta DA, Weiss B, Cox C. Delayed behavioral toxicity of lead with increasing exposure concentration. Toxicol Appl Pharmacol 71:342-352 (1983).
23. Calabrese EJ, Baldwin LA. U-shaped dose-responses in biology, toxicology, and public health. Annu Rev Public Health 22:15-33 (2001).
24. vom Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA, Nagel SC, Dhar MD, Ganjam VK, Parmigiani S, Welshons WV. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 94:2056-2061 (1997).